The prevalence as of 2021 of<unk>  is around 527,500 cases, with over 60,000 new patients reported globally in 2017. Prevalence has trended somewhat downward since 2015. The mortality of<unk>  patients remained at a high level in recent years, with over 21,000 deaths each year since 2015. It is likely that<unk>  is under-diagnosed and under-reported, especially in countries without highly developed healthcare systems.
Pneumoconiosis
Atypical pneumonia
Emphysema
Pulmonary fibrosis
Chemical pneumonitis
Plastic bronchitis
Bronchiectasis
Silicosis